Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo-Reference-Cited by-同舟云学术

Comparison of weakness progression in inclusion body myositis during treatment with methotrexate or placebo

Published:2002-02-27 Issue:3 Volume:51 Page:369-372
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol.

Author:

Badrising Umesh A.,Maat-Schieman Marion L.C.,Ferrari Michel D.,Zwinderman Aeilko H.,Wessels Judith A.M.,Breedveld Ferdinand C.,van Doorn Pieter A.,van Engelen Baziel G.M.,Hoogendijk Jessica E.,Höweler Chris J.,de Jager Aeiko E.,Jennekens Frans G.I.,Koehler Peter J.,de Visser Marianne,Viddeleer Alain,Verschuuren Jan J.,Wintzen Axel R.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Reference19 articles.

1. Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging;Askanas;Scand J Rheumatol,1998

2. Rimmed vacuoles of inclusion body myositis and oculopharyngeal muscular dystrophy contain amyloid precursor protein and lysosomal markers;Villanova;Brain Res,1993

3. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion- body myopathy;Sarkozi;Am J Pathol,1994

4. Sporadic inclusion body myositis: counts of different types of abnormal fibers;Pruitt;Ann Neurol,1996

5. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM;Dalakas;Neurology,2001

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Les actualités sur les myopathies inflammatoires;Revue du Rhumatisme;2023-12

2. Exploring challenges in the management and treatment of inclusion body myositis;Current Opinion in Rheumatology;2023-07-25

3. Dermatomyositis: a comprehensive review of clinical manifestations, serological features, and therapeutic approaches;Italian Journal of Dermatology and Venereology;2023-05

4. Clinical Subgroups and Factors Associated With Progression in Patients With Inclusion Body Myositis;Neurology;2023-03-28

5. Autoimmune inflammatory myopathies;Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders;2023